morphine high potency injection (Astramorph, Duramorph, Infumorph, AVINza) (cont.)

Pharmacy Author:
Medical and Pharmacy Editor:

DOSING: Dosing is specific to the route of administration. In adults (at least 18 years of age) the initial intravenous dose should be 2 to 10 mg per 70 kg of body weight over 24 hours. For epidural administration, 5 mg may be administered initially, with a maximum dose of 10 mg over 24 hours. Initial dosing for intrathecal administration should be 0.2 to 1 mg over 24 hours.

DRUG INTERACTIONS: Combining alcohol and other sedatives with morphine can lead to increased sedation and even cause confusion.

Fluoxetine (Prozac) may increase blood levels and the effect of morphine leading to increased side effects.

Morphine should also be avoided in patients treated with monoamine oxidase inhibitors (MAOI) due to enhance toxicity of morphine including confusion, high blood pressure, tremor, hyperactivity, coma, and death. Drugs in this class include isocarboxazid (Marplan), phenelzine (Nardil), tranylcypromine (Parnate), selegiline (Eldepryl), and procarbazine (Matulane), and linezolid (Zyvox). Morphine should not be administered within 14 days of stopping an MAOI.

PREGNANCY: Morphine injection should only be given to pregnant women when no other method of controlling pain is available and there are methods to monitor the fetus. Newborns may exhibit withdrawal symptoms if chronic dosing is used.

NURSING MOTHERS: Morphine is excreted in breast milk, however, the American Academy of Pediatrics committee states that it is safe to use while nursing

REFERENCE: FDA Prescribing Information

Medically Reviewed by a Doctor on 3/19/2015

Report Problems to the Food and Drug Administration

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

Pill Finder Tool

Need help identifying pills and medications?
Use the pill identifier tool on RxList.

Back to Medications Index